Latest Posts › China

Share:

New Implementing Regulations of China’s Anti-Monopoly Law: Highlights and Implications

Following last year’s significant amendments to the PRC Anti-Monopoly Law (2022 AML) the State Administration for Market Regulation (SAMR) has published final versions of the accompanying implementing regulations. Taking...more

The beginning of a new era: China amends its antitrust code for the first time

Amendments to China’s Anti-Monopoly Law, together with proposed revisions to various implementing regulations, are set to make substantial changes to both SAMR’s antitrust procedures and its substantive assessments. Key...more

Greater China Risk Insight: Looking ahead in the Year of the Tiger

The last two years have reshaped the global economy and socioeconomic policies, and have given rise to new risks and challenges. The world of disputes is also rapidly evolving. As we look back to reflect on the lessons...more

Proposed Amendments to the Anti-Monopoly Law: China further confirms its intention to strengthen its antitrust rules

China has made no secret that it intends to reinforce its antitrust regime. Multiple guidelines have been recently issued and enforcement mainly (but not only) against internet companies has substantially increased. ...more

China issues record antitrust fine

On Saturday 10 April 2021, the State Administration for Market Regulation (SAMR) issued a landmark decision, penalising the Chinese e-commerce group Alibaba for abusing its dominant position. The Chinese authority imposed a...more

Will the EU-China Comprehensive Agreement facilitate investment by EU companies in China?

The European Union (EU) and the People’s Republic of China concluded the negotiations on their investment treaty, the EU/China Comprehensive Agreement on Investment (CAI), on 30 December 2020. ...more

1/11/2021  /  China , EU , Investment

Coronavirus: Points to consider on M&A transactions

As coronavirus (Covid-19), first reported in Wuhan in December 2019, spreads across China and beyond, it has been widely reported that some Chinese companies are looking to suspend or terminate their contractual commitments....more

China’s new anti-bribery agency announces pharma probe

China’s State Administration for Market Regulation (SAMR) has announced the launch of a nationwide campaign to crack down on unfair competition and commercial bribery in the pharmaceutical, medical device and educational...more

Dawn of a New Era in Chinese Merger Control?

The Chinese merger control landscape evolves as MOFCOM is replaced by the newly created State Administration for Market Regulation (SAMR) as the country’s merger control agency. This change becomes fully effective on 14 May...more

5/15/2018  /  China , Merger Controls , Mergers , MOFCOM

China’s Draft IPR Guidelines Reach Final Consultation Stages

Speed read - On 23 March 2017, the Antimonopoly Commission of China’s State Council (“AMC”) published the long-expected draft Guidelines on Prohibition of Abuses of Intellectual Property Rights (“draft IPR Guidelines”)...more

4/4/2017  /  Anti-Monopoly , China , MOFCOM , NDRC , SAIC , SIPO

Antitrust in China: 2016 highlights and an outlook on 2017

The three Chinese antitrust authorities – Ministry of Commerce (MOFCOM), the National Development and Reform Commission (NDRC) and the State Administration for Industry and Commerce (SAIC) – overall remained very active in...more

3/1/2017  /  Anti-Monopoly , China , Competition , MOFCOM , NDRC , Popular

China Merger Control: MOFCOM Mounting Pressure On Failure To Notify Reportable Transactions

China’s MOFCOM continues to actively pursue companies failing to notify deals. Three new fine decisions published on 3 May 2016 illustrate a trend toward enhanced scrutiny and greater severity. Companies are targeted...more

When Does An IP Owner Become An IP Abuser?

Over the last two years, China has ramped up its efforts with antitrust enforcement. This also includes IP related abuse. But what does IP abuse mean? IP law confers the right to exclude – which means that an IP owner can...more

China’s Allopurinol Case: Double Jeopardy For One Anti-Competitive Scheme?

Two successive decisions from the SAIC and the NDRC, the Chinese antitrust agencies in charge of prosecuting cartels and abuses of dominance, in the same matter concerning allopurinol, a commonly used generic pharmaceutical...more

Antitrust in China: NDRC v. Qualcomm – One All

On 10 February 2015, China fined Qualcomm CNY6.08 billion (approx. USD975m or EUR870m) for abusive patent licensing practices and imposed several remedies on the company. ...more

15 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide